Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') OR or Authorisation for Early Access (AAP). A Prospectvie Cohort.
Clinical trial NCT04885452 · COMPLETED
Trial details
- NCT number
- NCT04885452
- Sponsor
- ANRS, Emerging Infectious Diseases
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-09-21
- Primary completion
- 2023-06-18
- Enrollment
- 756
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.